RESUMO
We previously described a series of cases which characterize a distinct group of primary ovarian placental site trophoblastic tumor (PSTT) and epithelioid trophoblastic tumor (ETT) as a non-gestational set consistent with germ cell type/origin. Here we report a new case of ovarian non-gestational PSTT. The patient was a 13 year-old young female admitted for a spontaneous pneumothorax of the left lung. The pathology of lung wedge excision specimen demonstrated metastatic PSTT and ovarian biopsy showed atypical intermediate trophoblastic proliferation which was found to be PSTT in the subsequent salpingo-oophorectomy specimen. In the ovary, the tumor was composed of singly dispersed or small clusters of predominantly mononuclear cells and rare multinucleated cells extensively infiltrating the ovarian parenchyma, tubal mucosa, and paraovarian/paratubal soft tissue. A minor component of mature cystic teratoma (less than 5% of total tumor volume) was present. Immunohistochemically, the neoplastic cells of main tumor were diffusely immunoreactive for hPL, Gata3 and AE1/AE3, and had only rare hCG-positive or p63-positive cells. The morphology and immunohistochemical results support a PSTT. Molecular genotyping revealed an identical genotype pattern between the normal lung tissue and the metastatic PSTT, indicating its non-gestational nature of germ cell type/origin. This case represents the first case of such tumor with distant (lung) metastasis. This case also provides further evidence to support our recommendation that primary ovarian non-gestational intermediate trophoblastic tumors of germ cell type/origin, including PSTT and ETT, should be formally recognized in classification systems.
Assuntos
Doença Trofoblástica Gestacional , Neoplasias Pulmonares , Neoplasias Trofoblásticas , Tumor Trofoblástico de Localização Placentária , Neoplasias Uterinas , Feminino , Humanos , Gravidez , Adolescente , Tumor Trofoblástico de Localização Placentária/química , Tumor Trofoblástico de Localização Placentária/patologia , Tumor Trofoblástico de Localização Placentária/cirurgia , Ovário/patologia , Placenta/patologia , Neoplasias Trofoblásticas/química , Neoplasias Trofoblásticas/patologia , Neoplasias Trofoblásticas/cirurgia , Doença Trofoblástica Gestacional/patologia , Neoplasias Uterinas/patologiaRESUMO
Non-choriocarcinomatous trophoblastic tumors (NCTTs) are seldomly diagnosed in male genital tract. As they have been recently described among the testicular germ cell tumor (TGCT) variants, pathologists' familiarity with their morphology is limited. We searched our electronic hospital records covering the years 2000-2017 for post-chemotherapy retroperitoneal TGCT metastectomies. Slides of all cases with viable tumor were retrieved from the archives and reviewed. Cases suspected of N-CTT morphologies were subjected to immunohistochemistry. Twelve NCTTs were identified, 9 of which were unseen or misdiagnosed by the original pathologists: Cystic trophoblastic tumor (CTT) (n = 5), placental site trophoblastic tumor (n = 2), epithelioid trophoblastic tumor (ETT) (n = 4), and coinciding PSTT + ETT (n = 1). Eight of these were associated with mature teratoma components, and one case (ETT) contained embryonal carcinoma and yolk sac tumor in addition to teratoma. Ten patients were clinically N1 at the time of primary tumor detection and orchiectomy. One patient had burned-out primary testicular tumor. Six patients were clinical M1a at presentation, while one male was cM1b. Six patients had mildly elevated ß-HCG (≤ 410 mIU/ml) just prior to retroperitoneal lymph node dissections (RPLND), while the others had normal ß-HCG levels. All patients had follow-ups ranging from 8 to 118 months (mean 42.3 months). Three patients died of disease-related and two of unrelated causes. In conclusion, because NCTTs are rare and newly described tumor types, their diagnosis is difficult and most of them are missed in post-chemotherapy RPLNDs. The majority of patients exhibit normal or slightly elevated ß-HCG levels. N-CTTs are usually accompanied by other components of TGCT, the most common being teratoma. Despite the high survival rate of the patients, our study points to the unpredictable evolution of NCTT cases, which may concur with a high-stage or progressive disease.
Assuntos
Doença Trofoblástica Gestacional , Neoplasias Embrionárias de Células Germinativas , Teratoma , Neoplasias Testiculares , Neoplasias Trofoblásticas , Humanos , Masculino , Feminino , Gravidez , Placenta/patologia , Neoplasias Trofoblásticas/patologia , Neoplasias Trofoblásticas/cirurgia , Neoplasias Testiculares/tratamento farmacológico , Neoplasias Testiculares/cirurgia , Neoplasias Testiculares/patologia , Excisão de Linfonodo , Teratoma/cirurgia , Teratoma/patologia , Espaço Retroperitoneal/patologiaAssuntos
Neoplasias Trofoblásticas , Humanos , Feminino , Gravidez , Neoplasias Trofoblásticas/cirurgiaAssuntos
Histerectomia/métodos , Neoplasias Trofoblásticas , Hemorragia Uterina , Neoplasias Uterinas , Diagnóstico Diferencial , Feminino , Humanos , Pessoa de Meia-Idade , Pós-Menopausa , Resultado do Tratamento , Neoplasias Trofoblásticas/patologia , Neoplasias Trofoblásticas/fisiopatologia , Neoplasias Trofoblásticas/cirurgia , Hemorragia Uterina/diagnóstico , Hemorragia Uterina/etiologia , Neoplasias Uterinas/patologia , Neoplasias Uterinas/fisiopatologia , Neoplasias Uterinas/cirurgiaRESUMO
Gestational trophoblastic tumors (GTTs) include choriocarcinoma, epithelioid trophoblastic tumor, and placental site trophoblastic tumor. The occurrence of mixed GTT is rare. We report such a case in a 24-year-old woman who presented with menorrhagia since 2 months and obstetric history of two abortions, one of which was a molar pregnancy. She was undergoing evaluation for carcinoma cervix and treatment for pulmonary tuberculosis from another hospital when she was admitted at our institute for further workup and treatment. However, she succumbed and an autopsy was performed. Histologic evaluation after the autopsy revealed uterine choriocarcinoma with metastatic epithelioid trophoblastic tumor (ETT) in the lung and spleen.
Assuntos
Coriocarcinoma/patologia , Neoplasias Pulmonares/secundário , Neoplasias Epiteliais e Glandulares/secundário , Neoplasias Esplênicas/secundário , Neoplasias Trofoblásticas/secundário , Neoplasias Uterinas/patologia , Adulto , Autopsia , Coriocarcinoma/complicações , Coriocarcinoma/cirurgia , Feminino , Humanos , Neoplasias Pulmonares/complicações , Neoplasias Pulmonares/cirurgia , Neoplasias Epiteliais e Glandulares/complicações , Neoplasias Epiteliais e Glandulares/cirurgia , Gravidez , Prognóstico , Neoplasias Esplênicas/complicações , Neoplasias Esplênicas/cirurgia , Neoplasias Trofoblásticas/complicações , Neoplasias Trofoblásticas/cirurgia , Neoplasias Uterinas/complicações , Neoplasias Uterinas/cirurgia , Adulto JovemRESUMO
We report the resection of a recurrent epithelioid trophoblastic tumor by laparoscopic laterally extended endopelvic resection (LEER). The LEER technique was developed to resect en bloc multiple visceral compartments involving the lateral pelvic wall with negative margins for local control of advanced and recurrent malignancies. Described by Höckel, this procedure is usually performed by a midline laparotomy. Our patient had undergone prior laparotomic surgery including hysterectomy, partial bladder resection, and a right ureteral reimplantation for an epithelioid trophoblastic tumor without adjuvant treatment. She presented a recurrent tumor infiltrating the bladder, the ureter, and the right pelvic wall as well as the internal and external iliac vessels. A vascular surgeon first performed a femorofemoral bypass by bilateral groin incisions with a subcutaneous tunnel. The surgery was then exclusively performed by laparoscopy using the LEER technique including resection of both external and internal iliac vessels and the pelvic wall through the lateral pelvic muscles and iterative bladder resection associated with a ureteral reimplantation using the psoas hitch bladder technique. The patient experienced Clavien-Dindo classification grade II postoperative complications. Histology showed a margin-free resection (R0).
Assuntos
Histerectomia/métodos , Recidiva Local de Neoplasia/cirurgia , Neoplasias Trofoblásticas/patologia , Neoplasias Trofoblásticas/cirurgia , Neoplasias Uterinas/patologia , Neoplasias Uterinas/cirurgia , Feminino , Humanos , Laparoscopia/métodos , Pessoa de Meia-Idade , Invasividade Neoplásica , Pelve/patologia , Pelve/cirurgia , Ureter/patologia , Ureter/cirurgiaRESUMO
Objective: To elucidate the clinicopathologic characteristics of atypical epithelioid trophoblastic lesions with cyst and fistula formation after cesarean section. Methods: The clinical and pathological data of 4 cases of post-cesarean atypical epithelioid trophoblastic lesions with cyst and fistula formation diagnosed at Women's Hospital, School of Medicine, Zhejiang University during April 2007 to June 2018 were evaluated by hematoxylin and eosin stain and EnVision two-step immunohistochemical staining technique. Results: The age of the 4 patients ranged from 32 to 41 years, with a mean age of 36.5 years. Three patients recieved cystectomy and one underwent subtotal hysterectomy. Histologically, the lesions were well circumscribed and consisted of uniform cells of medium size, irregularly enlarged with hyperchromatic nuclei and 1 to 2 inconspicuous nucleoli embedded in abundant hyalinized matrix with fibrinoid material in the center. The cells exhibited immunohistochemical feature of chorionic-type intermediate trophoblastic cells (CK18+, p63+ and CD146-). All patients were alive without recurrence during follow-up of 1 to 40 months (mean=22 months). Conclusion: Atypical epithelioid trophoblastic lesion with cyst and fistula formation after cesarean section has unique histological features, and its biological behavior and prognosis are still unclear, which need further exploration.
Assuntos
Cesárea/efeitos adversos , Cistos/patologia , Células Epitelioides/patologia , Fístula/patologia , Complicações Pós-Operatórias/patologia , Neoplasias Trofoblásticas/patologia , Neoplasias Uterinas/patologia , Adulto , Cistos/etiologia , Cistos/cirurgia , Feminino , Fístula/etiologia , Fístula/cirurgia , Humanos , Imuno-Histoquímica , Recidiva Local de Neoplasia , Complicações Pós-Operatórias/etiologia , Complicações Pós-Operatórias/cirurgia , Gravidez , Neoplasias Trofoblásticas/etiologia , Neoplasias Trofoblásticas/cirurgia , Doenças Uterinas/etiologia , Doenças Uterinas/patologia , Neoplasias Uterinas/etiologia , Neoplasias Uterinas/cirurgiaRESUMO
INTRODUCTION: An epithelial trophoblastic tumor (ETT) is a kind of rare trophoblastic tumor that may have the correlation with a prior gestational event. Especially, the one that appears in the lung is extremely rare. CASE SUMMARY: Here, we present a 24-year-old female patient with the chief complain of vaginal bleeding for more than 1 month, who was found to have a large mass (7.5â×â4.5âcm) in the right lower lobe, and it was finally confirmed as lung ETT by postoperative pathology after a successful radical resection of the pulmonary lobe. CONCLUSIONS: As the reason of an extreme rare occurrence of the ETT, doctors can easily misdiagnose the disease. When the patient was found to have a mass with irregular vaginal bleeding and a high level of beta-human chorionic gonadotropin, we need to consider ETT. Currently, surgery is still the most effective method.
Assuntos
Neoplasias Pulmonares/diagnóstico , Neoplasias Pulmonares/cirurgia , Neoplasias Epiteliais e Glandulares/diagnóstico , Neoplasias Epiteliais e Glandulares/cirurgia , Neoplasias Trofoblásticas/diagnóstico , Neoplasias Trofoblásticas/cirurgia , Diagnóstico Diferencial , Erros de Diagnóstico , Feminino , Humanos , Pulmão/diagnóstico por imagem , Pulmão/cirurgia , Adulto JovemRESUMO
OBJECTIVE: Epithelioid trophoblastic tumor is a rare gestational trophoblastic neoplasm usually presenting in women of reproductive age, with a history of a prior gestational event. Its presentation in postmenopausal women is extremely rare. Immunohistochemical staining is a helpful aid to distinguish epithelioid trophoblastic tumor from other gestational trophoblastic neoplasms. Correct diagnosis is crucial for clinical management that can vary according to the type of gestational trophoblastic neoplasm. METHODS: We report the case of a 63-year-old postmenopausal woman 33 years after her last full-term pregnancy and another case of a 57-year-old postmenopausal woman who had had a first-trimester abortion 30 years previously as her last gestational event, both presenting cervical epithelioid trophoblastic tumors. In both cases, immunohistochemistry played an important role in differentiating this entity from other gestational trophoblastic neoplasms. Surgery was the primary treatment in both cases. The first patient remained disease-free and died 5 years later due to a rectal adenocarcinoma, and the second patient remains disease-free at publication. RESULTS: In both cases, the hysterectomy specimen confirmed the presence of two large epithelioid trophoblastic tumors arising in the endocervix and lower uterine segment with no extrauterine disease. Nuclear positivity for p63 allowed differentiation from a placental site trophoblastic tumor. The Ki67 proliferative index was 20% and 35%, respectively. CONCLUSIONS: Epithelioid trophoblastic tumors may occur a long time after a prior gestational event and should even be excluded in postmenopausal women with uterine masses. Immunohistochemical staining is helpful to make the differential diagnosis with other gestational trophoblastic neoplasms.
Assuntos
Pós-Menopausa , Neoplasias Trofoblásticas/diagnóstico , Neoplasias Uterinas/diagnóstico , Colo do Útero/patologia , Diagnóstico Diferencial , Feminino , Humanos , Histerectomia , Pessoa de Meia-Idade , Gravidez , Neoplasias Trofoblásticas/cirurgia , Neoplasias Uterinas/cirurgiaRESUMO
Cystic trophoblastic tumor (CTT) has been described in postchemotherapy retroperitoneal lymph node dissections of patients with testicular germ cell tumors. Prognostically, this lesion is similar to teratoma and no further treatment is required after surgery in the absence of other components. CTT has not, however, been reported in the testis. We identified 14 CTTs in the treated (4) and untreated (9; no information for 1 patient) testes of patients 15 to 43 years old (median, 25) with mixed germ cell tumors. The CTT was a minor component (<1% to 10%) and associated with teratoma (14), embryonal carcinoma (7), yolk sac tumor (7), seminoma (1), and choriocarcinoma (1). At follow-up, CTT and teratoma were also found in 2 subsequent resections (spermatic cord and pelvis mass) in 2 patients. The CTTs were not grossly distinct but on microscopic examination were cystic to partly solid, with cysts often containing fibrinoid material and lined by mononucleated squamoid cells with eosinophilic to pale, frequently vacuolated cytoplasm and having pleomorphic nuclei with dense, often smudged chromatin. Mitotic activity was inconspicuous. Immunostains for hCG (6/6), inhibin (6/6), and p63 (2/6) were focally positive. The pathogenesis of CTT is not completely understood. As untreated patients without choriocarcinoma may have CTT in the testis, it is suggested that testicular CTT represents a form of regressed choriocarcinoma or a late morphologic phase in the transformation of choriocarcinoma to teratoma.
Assuntos
Neoplasias Testiculares/diagnóstico , Neoplasias Trofoblásticas/diagnóstico , Adolescente , Adulto , Feminino , Seguimentos , Humanos , Masculino , Orquiectomia , Análise de Sobrevida , Neoplasias Testiculares/mortalidade , Neoplasias Testiculares/patologia , Neoplasias Testiculares/cirurgia , Resultado do Tratamento , Neoplasias Trofoblásticas/mortalidade , Neoplasias Trofoblásticas/patologia , Neoplasias Trofoblásticas/cirurgia , Adulto JovemRESUMO
OBJECTIVE: To describe a case of epithelioid trophoblastic tumor (ETT) in a postmenopausal woman, which had several peculiar features that differentiate it from previously reported ETTs. CASE REPORT: ETT of the uterus is a rare form of trophoblastic tumor with only 100 cases distinguished until now. Our case differs from the previously reported ones due to its several exceptional features. Our patient had no history of trophoblastic or gynecological disease; is postmenopausal; had endocervical extension from the beginning; recurrences and metastasis at follow up; and had a high Ki-67 index and a normal beta-human chorionic gonadotropin value. CONCLUSION: Because precise differential diagnosis will alter the therapeutic approach and prognosis, it is necessary for treating physicians to be aware of these unusual presentations.
Assuntos
Células Epitelioides/patologia , Histerectomia/métodos , Neoplasias Trofoblásticas/diagnóstico , Neoplasias Uterinas/diagnóstico , Biópsia , Diagnóstico Diferencial , Feminino , Humanos , Pessoa de Meia-Idade , Tomografia Computadorizada por Raios X , Neoplasias Trofoblásticas/cirurgia , Neoplasias Uterinas/cirurgiaRESUMO
Gestational trophoblastic neoplasms are a group of fetal trophoblastic tumors including choriocarcinomas, epithelioid trophoblastic tumors (ETTs), and placental site trophoblastic tumors (PSTTs). Mixed gestational trophoblastic neoplasms are extremely rare. The existence of mixed gestational trophoblastic neoplasms that were composed of choriocarcinoma and/or PSTT and/or ETT was also reported. Herein, we present a case of uterine mixed gestational trophoblastic neoplasm which is ETT admixed with PSTT, and reviewed 9 cases of mixed gestational trophoblastic neoplasms reported in English literature available. The most common combination was a choriocarcinoma admixed with an ETT and/or PSTT. Mixed gestational trophoblastic neoplasms present in women of reproductive age and rare in postmenopausal, Abnormal vaginal bleeding is the most common presenting symptom, serum ß-HCG levels are elevated, mostly below 2500 mIU/ml, the tumor was limited to uterus in 7 cases, the rest of 3 with pulmonary metastases at the time of diagnosis. Mixed gestational trophoblastic neoplasms have more similar clinical features with intermediate trophoblastic tumors (ITTs). Total hysterectomy with lymph node dissection is recommended treatment for mixed gestational trophoblastic neoplasms, and chemotherapy should be used in patients with metastatic disease and with nonmetastatic disease who have adverse prognostic factors.
Assuntos
Células Epitelioides/patologia , Neoplasias Complexas Mistas/patologia , Nascimento a Termo , Neoplasias Trofoblásticas/patologia , Tumor Trofoblástico de Localização Placentária/patologia , Neoplasias Uterinas/patologia , Adulto , Biomarcadores Tumorais/análise , Biópsia , Células Epitelioides/química , Feminino , Humanos , Histerectomia , Imuno-Histoquímica , Laparoscopia , Neoplasias Complexas Mistas/química , Neoplasias Complexas Mistas/cirurgia , Ovariectomia , Gravidez , Salpingectomia , Neoplasias Trofoblásticas/química , Neoplasias Trofoblásticas/cirurgia , Tumor Trofoblástico de Localização Placentária/química , Tumor Trofoblástico de Localização Placentária/cirurgia , Miomectomia Uterina/métodos , Neoplasias Uterinas/química , Neoplasias Uterinas/cirurgiaRESUMO
Postmolar malignant conditions are rare after evacuation of a complete molar pregnancy. Both medical and surgical management have a role in the treatment of persistent gestational trophoblastic neoplasia. Treatment decisions must account for the natural history of the disease, previous therapies, site of disease, and the patient's desire for uterine preservation. We report on a woman who presented with chemotherapy-refractory persistent gestational trophoblastic disease (GTD). She was found to have isolated, persistent trophoblastic tissue within the uterine myometrium. She underwent a robotic-assisted laparoscopic hysterectomy with curative results. Minimally invasive surgical management may be an option for treatment of women with isolated myoinvasive GTD.
Assuntos
Doença Trofoblástica Gestacional/patologia , Histerectomia , Laparoscopia , Miométrio/patologia , Procedimentos Cirúrgicos Robóticos , Neoplasias Trofoblásticas/cirurgia , Neoplasias Uterinas/cirurgia , Adulto , Feminino , Doença Trofoblástica Gestacional/complicações , Humanos , Mola Hidatiforme/patologia , Mola Hidatiforme/cirurgia , Histerectomia/métodos , Miométrio/cirurgia , Gravidez , Resultado do Tratamento , Neoplasias Trofoblásticas/tratamento farmacológico , Neoplasias Trofoblásticas/patologia , Neoplasias Uterinas/tratamento farmacológico , Neoplasias Uterinas/patologiaRESUMO
OBJECTIVE: We present a case of primary cornual epithelioid trophoblastic tumor (ETT) because of its rarity and diagnostic and therapeutic challenge. CASE REPORT: A 28-year-old woman, gravida 1, para 1, who missed menstruation for 3 months, had an elevated ß-human chorionic gonadotropin serum level of 2764 mIU/mL, an absence of intrauterine pregnancy, and the presence of an adnexal mass detected by transvaginal ultrasound. As an ectopic pregnancy was suspected, laparoscopic surgery was performed and showed a right corneal mass. Complete excision of the tumor was done through exploratory laparotomy. Frozen pathology favored the diagnosis of squamous cell carcinoma. Since there was no apparent tumor at other sites, no additional surgery was done. The final pathology showed ETT. Primary ETT is often misdiagnosed as an ectopic pregnancy, leading to delayed treatment, and poses a diagnostic challenge in distinguishing it from squamous cell carcinoma during pathological examination. CONCLUSION: Careful evaluation and avoidance of overtreatment are emphasized.
Assuntos
Gravidez Ectópica/diagnóstico , Neoplasias Trofoblásticas/diagnóstico por imagem , Neoplasias Trofoblásticas/patologia , Neoplasias Uterinas/diagnóstico por imagem , Neoplasias Uterinas/patologia , Adulto , Carcinoma de Células Escamosas/patologia , Diagnóstico Diferencial , Feminino , Humanos , Gravidez , Neoplasias Trofoblásticas/cirurgia , Ultrassonografia , Neoplasias Uterinas/cirurgiaRESUMO
A 40-year-old woman presented to our institution with abnormal uterine bleeding, elevated ß-human chorionic gonadotropin levels, and a mass in the left lower lobe of her lung. She underwent a thoracoscopic lobectomy after further staging and workup revealed no other abnormalities. Pathologic examination of the lung mass revealed an epithelioid trophoblastic tumor. In patients with elevated ß-human chorionic gonadotropin levels, a lung mass, and a negative gynecologic examination, primary epithelioid trophoblastic tumor of the lung should be considered.
Assuntos
Neoplasias Pulmonares , Neoplasias Trofoblásticas , Criança , Feminino , Humanos , Neoplasias Pulmonares/diagnóstico , Neoplasias Pulmonares/cirurgia , Masculino , Neoplasias Trofoblásticas/diagnóstico , Neoplasias Trofoblásticas/cirurgiaRESUMO
Pulmonary extrauterine epithelioid trophoblastic tumors (ETTs) are extremely rare. A 26-year-old nonsmoking woman with a history of a suspected subclinical miscarriage presented with a large mass in the right lower lobe that was confirmed to be a pulmonary extrauterine ETT using immunohistochemical stains. When a nonsmoking fertile woman presents with a pulmonary mass and an elevated serum ß-human chorionic gonadotrophin in the absence of gynecologic disease, pulmonary extrauterine ETT should be considered.
Assuntos
Células Epitelioides/patologia , Neoplasias Pulmonares/patologia , Neoplasias Trofoblásticas/patologia , Adulto , Biomarcadores Tumorais/análise , Biomarcadores Tumorais/sangue , Biópsia , Quimioterapia Adjuvante , Gonadotropina Coriônica Humana Subunidade beta/sangue , Células Epitelioides/química , Feminino , Humanos , Imuno-Histoquímica , Neoplasias Pulmonares/sangue , Neoplasias Pulmonares/química , Neoplasias Pulmonares/cirurgia , Excisão de Linfonodo , Pneumonectomia , Cirurgia Torácica Vídeoassistida , Toracotomia , Tomografia Computadorizada por Raios X , Resultado do Tratamento , Neoplasias Trofoblásticas/sangue , Neoplasias Trofoblásticas/química , Neoplasias Trofoblásticas/cirurgiaRESUMO
An epithelioid trophoblastic tumor (ETT) is a form of gestational trophoblastic neoplasms that arise from trophoblasts. The tumor generally occurs in women of reproductive age and has a characteristic growth pattern and immunohistochemical profile. We present an extremely rare case of a primary ETT occurring in the lungs with an adenocarcinoma in the contralateral lung as synchronous double primary lung cancers in a 69-year-old man who had no history of a remote malignancy. He underwent adjuvant radiotherapy to both lungs after a staged thoracoscopic wedge resection and was doing well without recurrence or metastasis up to last follow-up.
Assuntos
Adenocarcinoma/cirurgia , Neoplasias Pulmonares/cirurgia , Neoplasias Primárias Múltiplas/cirurgia , Neoplasias Trofoblásticas/cirurgia , Adenocarcinoma/patologia , Adenocarcinoma/radioterapia , Idoso , Células Epitelioides/metabolismo , Células Epitelioides/patologia , Feminino , Seguimentos , Humanos , Neoplasias Pulmonares/patologia , Neoplasias Pulmonares/radioterapia , Masculino , Neoplasias Primárias Múltiplas/patologia , Neoplasias Primárias Múltiplas/radioterapia , Cuidados Pós-Operatórios , Radioterapia Adjuvante , Toracoscopia , Resultado do Tratamento , Neoplasias Trofoblásticas/patologia , Neoplasias Trofoblásticas/radioterapiaRESUMO
CONTEXT: Previous experimental and clinical data suggest impaired decidual trophoblast invasion in patients with polycystic ovarian syndrome (PCOS). OBJECTIVE: The objective of the study was to test the hypothesis that decidual endovascular trophoblast invasion in pregnant patients with PCOS is impaired and to clarify the potential mechanisms involved. DESIGN: This was an experimental case-control study. SETTING: The study was conducted at the academic Departments of Obstetrics and Gynecology and the Unit of Pathology (Italy). PATIENTS: Forty-five pregnant subjects screened from a wide population of women waiting for legal pregnancy termination were included in the final analysis. Specifically, 15 pregnant patients with PCOS were enrolled as cases and another 30 age- and body mass index (BMI)-matched healthy pregnant women without any feature of PCOS were enrolled as the controls. INTERVENTION: Interventions included the collection of trophoblastic and decidual tissue at the 12th week of gestation. MAIN OUTCOME MEASURES: Clinical, ultrasonographic, and biochemical data as well as the histological analysis of decidual endovascular trophoblast invasion. RESULTS: The rate of implantation site vessels with endovascular trophoblast invasion (ratio between total number of implantation site vessels and total number of vessels with endovascular trophoblast invasion) and the extent of endovascular trophoblast invasion (proportion between immunoreactive areas to cytokeratin 7 and to CD34) were significantly lower in patients with PCOS compared with healthy non-PCOS controls. Endovascular trophoblast invasion data were significantly and indirectly related to the markers of insulin resistance and testosterone concentrations in PCOS patients. CONCLUSIONS: Pregnant patients with PCOS patients have impaired decidual trophoblast invasion. Further studies are needed to evaluate the exact mechanisms through which insulin resistance and hyperandrogenemia exert this effect.
Assuntos
Decídua/patologia , Síndrome do Ovário Policístico/complicações , Complicações na Gravidez/patologia , Neoplasias Trofoblásticas/patologia , Trofoblastos/patologia , Neoplasias Uterinas/patologia , Aborto Terapêutico/estatística & dados numéricos , Adulto , Estudos de Casos e Controles , Decídua/irrigação sanguínea , Feminino , Humanos , Invasividade Neoplásica , Síndrome do Ovário Policístico/diagnóstico por imagem , Síndrome do Ovário Policístico/epidemiologia , Síndrome do Ovário Policístico/cirurgia , Gravidez , Complicações na Gravidez/diagnóstico por imagem , Complicações na Gravidez/epidemiologia , Complicações na Gravidez/cirurgia , Complicações Neoplásicas na Gravidez/epidemiologia , Complicações Neoplásicas na Gravidez/patologia , Complicações Neoplásicas na Gravidez/cirurgia , Complicações Neoplásicas na Gravidez/terapia , Neoplasias Trofoblásticas/complicações , Neoplasias Trofoblásticas/epidemiologia , Neoplasias Trofoblásticas/cirurgia , Ultrassonografia , Neoplasias Uterinas/complicações , Neoplasias Uterinas/epidemiologia , Neoplasias Uterinas/cirurgia , Adulto JovemRESUMO
Uterine morcellation is performed only when significant neoplasia is not anticipated. In this study, we aimed to determine the prevalence of unexpected pathology in a series of low-risk morcellated hysterectomies. We reviewed a series consisting of all patients undergoing hysterectomy with morcellation at a tertiary-care hospital over a 4-yr period (n=101). Patient records were reviewed to retrieve demographics, details of preoperative evaluation (Pap smear, endometrial biopsy, imaging), and surgical pathology diagnoses. The median number of blocks submitted for histology was 6. On final pathology, endometrium was detected in 99% of all cases. No endometrial, myometrial, or cervical neoplasia other than leiomyoma (numerous cases) was present in the morcellated uteri, but in 1 case an atypical trophoblastic nodule with necrosis and myometrial infiltration, suspected to represent epithelioid trophoblastic tumor, was inadvertently morcellated. From this series, the prospective risk of occult malignancy in a low-risk population undergoing morcellation is estimated at 1% (95% confidence interval, <0.01%-5.94%). A subgroup analysis of patients who participated in what we propose as a complete preoperative workup, consisting of nonconcerning Pap smear, endometrial biopsy, and ultrasound or magnetic resonance imaging, showed no significant findings on final histology. Even with a complete workup, however, morcellation of occult uterine malignancy remains a possibility. This risk should be discussed as part of informed consent before morcellation.